Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Undiscovered Gems in Hong Kong for September 2024

In This Article:

In recent weeks, the Hong Kong market has faced challenges amid broader global economic concerns, with key indices reflecting a cautious investor sentiment. Despite this backdrop, small-cap stocks in Hong Kong continue to offer unique opportunities for those willing to explore beyond the well-trodden paths. In such a volatile environment, identifying stocks with strong fundamentals and growth potential becomes even more critical. This article will highlight three undiscovered gems in Hong Kong that could stand out in September 2024.

Top 10 Undiscovered Gems With Strong Fundamentals In Hong Kong

Name

Debt To Equity

Revenue Growth

Earnings Growth

Health Rating

COSCO SHIPPING International (Hong Kong)

NA

-3.84%

16.33%

★★★★★★

Changjiu Holdings

NA

11.84%

2.46%

★★★★★★

China Leon Inspection Holding

8.55%

21.36%

22.77%

★★★★★★

Tianyun International Holdings

10.09%

-5.59%

-9.92%

★★★★★★

Xin Point Holdings

1.77%

10.88%

22.83%

★★★★★☆

Chongqing Machinery & Electric

28.07%

8.82%

11.12%

★★★★★☆

HBM Holdings

52.89%

66.59%

31.70%

★★★★★☆

TIL Enviro

47.97%

-23.09%

-8.84%

★★★★☆☆

Pizu Group Holdings

48.34%

-4.53%

-19.78%

★★★★☆☆

Billion Industrial Holdings

3.63%

18.00%

-11.38%

★★★★☆☆

Click here to see the full list of 174 stocks from our SEHK Undiscovered Gems With Strong Fundamentals screener.

We'll examine a selection from our screener results.

IVD Medical Holding

Simply Wall St Value Rating: ★★★★★☆

Overview: IVD Medical Holding Limited, an investment holding company with a market cap of HK$2.13 billion, distributes in vitro diagnostic (IVD) products in Mainland China and internationally.

Operations: IVD Medical Holding generates revenue primarily from its distribution business (CN¥2.86 billion), followed by after-sales services (CN¥196.47 million) and self-branded products (CN¥9.05 million).

IVD Medical Holding reported a net income of CNY 125.29 million for the first half of 2024, up from CNY 103.01 million last year, with basic earnings per share rising to CNY 0.0927 from CNY 0.0762. The company repurchased shares worth HKD 189.64 million recently and has been growing faster than the healthcare industry, with earnings growth at 12.3% compared to the industry's -11.6%. Despite high volatility in its share price over the past three months, IVD Medical's debt is well-covered by EBIT at a ratio of 20.8x and it holds more cash than total debt.

SEHK:1931 Earnings and Revenue Growth as at Sep 2024
SEHK:1931 Earnings and Revenue Growth as at Sep 2024

YesAsia Holdings

Simply Wall St Value Rating: ★★★★★★

Overview: YesAsia Holdings Limited, an investment holding company, engages in the procurement, sale, and trading of Asian fashion and lifestyle, beauty, cosmetics, accessories, and entertainment products with a market cap of HK$2.59 billion.